|
 Global COVID-19 cases hit 250 million
Global COVID-19 cases surpassed 250 million on Monday as some
countries in eastern Europe report record outbreaks, even as the
Delta variant surge eases elsewhere and many countries resume trade
and tourism. The daily average number of cases has fallen by 36%
over the past three months, according to a Reuters analysis, but the
virus is still infecting 50 million people every 90 days due to the
highly transmissible Delta variant.
Infections are still rising in 55 out of 240 countries, with Russia,
Ukraine and Greece at or near record levels of reported cases since
the pandemic started two years ago, according to a Reuters analysis.
More than half the world's population has yet to receive a single
dose of a COVID-19 vaccine, according to Our World in Data, a figure
that drops to less than 5% in low-income countries.
Australia begins vaccine booster rollout as more curbs ease
Australia began administering booster shots of Pfizer's COVID-19
vaccine on Monday as millions of people in its largest city, Sydney,
woke up to more freedom amid an accelerating immunisation drive.
There are now no limits on the number of fully vaccinated guests at
homes, while restaurants and entertainment venues can allow more
patrons. Stadiums can operate at full capacity.
After more than 18 months of some of the world's strictest
containment policies, border restrictions have started to ease,
setting in motion a plan to reopen the country to travellers amid a
gaping hole in the market for casual workers.
U.S. braces for surge of vaccinated international travelers
The United States is expecting a flood of international visitors
crossing its borders by air and by land on Monday after lifting
travel restrictions for much of the world's population first imposed
in early 2020 to address the spread of COVID-19.
[to top of second column] |
Passengers will need to show an "official source" showing
vaccination status, and airlines will need to match the name and
date of birth to confirm the passenger is the same person reflected
on the proof of vaccination.
UK to roll out COVID-19 antiviral drug trial this month
Britain will start to roll out Merck's molnupiravir COVID-19
antiviral pill through a drug trial later this month, Susan Hopkins,
Chief Medical Adviser at the UK Health Security Agency said on
Sunday.
Last week Britain became the first country in the world to approve
the potentially game-changing COVID-19 antiviral pill, jointly
developed by U.S.-based Merck & Co Inc and Ridgeback Biotherapeutics.
German coalition parties to table coronavirus draft law on Monday
The three German parties working to agree on a coalition government
by early December will present proposals to combat a raging fourth
wave of the COVID-19 pandemic in the country on Monday, daily
newspaper Die Welt said.
The plan, which includes the reintroduction of free tests, comes
from the SPD, Greens and Free Democrats, which together hold a
parliamentary majority, and will be discussed by the Bundestag, the
lower house of parliament, later this week. It is aimed to come into
force before a national state of epidemic emergency expires on Nov.
25.
(Compiled by Karishma Singh; Editing by Lincoln Feast.)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content
 |
